INHBB variants as genetic determinants of breast density modulate breast cancer risk

被引:0
|
作者
Taherian, Vahideh [1 ]
Shamshiri, Asma Khorshid [1 ]
Vakili, Fatemeh [2 ]
Shandiz, Fatemeh Homaei [3 ]
Farrokh, Donya [4 ]
Pasdar, Alireza [1 ,5 ]
Afzaljavan, Fahimeh [6 ]
机构
[1] Mashhad Univ Med Sci, Fac Med, Dept Genet & Mol Med, Mashhad, Razavi Khorasan, Iran
[2] Mashhad Univ Med Sci, Fac Nursing & Midwifery, Midwifery Dept, Mashhad, Razavi Khorasan, Iran
[3] Mashhad Univ Med Sci, Canc Res Ctr, Mashhad, Razavi Khorasan, Iran
[4] Mashhad Univ Med Sci, Imam Reza Hosp, Fac Med, Dept Radiol, Mashhad, Razavi Khorasan, Iran
[5] Univ Aberdeen, Med Sch, Div Appl Med, Aberdeen AB25 2ZD, Scotland
[6] Mashhad Univ Med Sci, Sch Med, Dept Obstet & Gynecol, Mashhad, Razavi Khorasan, Iran
来源
HUMAN GENE | 2024年 / 42卷
关键词
Breast cancer; Mammographic density; Breast density; Polymorphism; INHBB gene; GENOME-WIDE ASSOCIATION; INHIBIN; ACTIVIN; EXPRESSION; SUBUNITS;
D O I
10.1016/j.humgen.2024.201326
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: One of the most common cancers worldwide is breast cancer (BC), which is influenced by genetics and environmental factors such as mammographic density. Studies suggested INHBB genetic polymorphisms as potential risk factors for breast cancer/density. Therefore, this study was conducted to validate this correlation in a cohort of the Iranian population. Methods: Five ml of peripheral blood was collected from 200 patients and 200 healthy women. Mammographic density was determined by mammograms. rs11902591, rs4328642, and rs10183524 of the INHBB gene were genotyped using the ARMS-PCR method. Haplotype frequencies and statistical analysis were estimated using PHASE and SPSS 16.0 software, respectively. Results: There was no association between rs1192591 and breast density, whereas this polymorphism was associated with breast cancer risk [per allele p = 0.040; OR = 0.56, 95%CI (0.32-0.97)]. Conversely, the C/T genotype of rs4328642 was significantly higher in individuals with dense breasts [p = 0.002; OR = 2.31, 95%CI (1.37-3.89)]. Furthermore, rs10183524 was statistically associated with breast density [p = 0.009; OR = 0.55, 95%CI (0.35-0.86)] and cancer risk [p = 0.031; OR = 0.52, 95%CI (0.29-0.94)]. Also, certain haplotypes and diplotypes of these markers were associated with BC risk and/or breast density. Conclusion: According to the findings, INHBB gene polymorphisms affect cancer risk and density of the breast, and the interaction between alleles in the form of haplotypes and diplotypes may modulate the amount of the risk conferred by these variants.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Identification of histopathologic determinants of mammographic breast density as a cancer risk factor
    Keller, B. M.
    Batiste, R. C.
    Chen, J.
    McDonald, E. S.
    Conant, E. F.
    Kontos, D.
    Feldman, M. D.
    CANCER RESEARCH, 2016, 76
  • [32] Genetic variants of CYP19 (aromatase) and breast cancer risk
    V Nedelcheva Kristensen
    N Harada
    N Yoshimura
    E Haraldsen
    PE Lønning
    B Erikstein
    R Kåresen
    T Kristensen
    A-L Børresen-Dale
    Breast Cancer Research, 2 (Suppl 1)
  • [33] Genetic variants in ultraconserved elements and risk of breast cancer in Chinese population
    Shen, Hao
    Lu, Cheng
    Jiang, Yue
    Tang, Jinhai
    Chen, Wei
    Zhang, Hanze
    Zhang, Qin
    Wang, Jianming
    Liang, Jie
    Hu, Zhibin
    Shen, Hongbing
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (03) : 855 - 861
  • [34] Genetic variants in ultraconserved elements and risk of breast cancer in Chinese population
    Hao Shen
    Cheng Lu
    Yue Jiang
    Jinhai Tang
    Wei Chen
    Hanze Zhang
    Qin Zhang
    Jianming Wang
    Jie Liang
    Zhibin Hu
    Hongbing Shen
    Breast Cancer Research and Treatment, 2011, 128 : 855 - 861
  • [35] Genetic Variants in Hormone-Related Genes and Risk of Breast Cancer
    Clendenen, Tess
    Zeleniuch-Jacquotte, Anne
    Wirgin, Isaac
    Koenig, Karen L.
    Afanasyeva, Yelena
    Lundin, Eva
    Arslan, Alan A.
    Axelsson, Tomas
    Forsti, Asta
    Hallmans, Goran
    Hemminki, Kari
    Lenner, Per
    Roy, Nirmal
    Shore, Roy E.
    Chen, Yu
    PLOS ONE, 2013, 8 (07):
  • [36] Genetic variants of the sulfotransferase 1A1 and breast cancer risk
    Langsenlehner, U
    Krippl, P
    Renner, W
    Yazdani-Biuki, B
    Eder, T
    Wolf, G
    Wascher, TC
    Paulweber, B
    Weitzer, W
    Samonigg, H
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 87 (01) : 19 - 22
  • [37] Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
    Mavaddat, Nasim
    Pharoah, Paul D. P.
    Michailidou, Kyriaki
    Tyrer, Jonathan
    Brook, Mark N.
    Bolla, Manjeet K.
    Wang, Qin
    Dennis, Joe
    Dunning, Alison M.
    Shah, Mitul
    Luben, Robert
    Brown, Judith
    Bojesen, Stig E.
    Nordestgaard, Borge G.
    Nielsen, Sune F.
    Flyger, Henrik
    Czene, Kamila
    Darabi, Hatef
    Eriksson, Mikael
    Peto, Julian
    dos-Santos-Silva, Isabel
    Dudbridge, Frank
    Johnson, Nichola
    Schmidt, Marjanka K.
    Broeks, Annegien
    Verhoef, Senno
    Rutgers, Emiel J.
    Swerdlow, Anthony
    Ashworth, Alan
    Orr, Nick
    Schoemaker, Minouk J.
    Figueroa, Jonine
    Chanock, Stephen J.
    Brinton, Louise
    Lissowska, Jolanta
    Couch, Fergus J.
    Olson, Janet E.
    Vachon, Celine
    Pankratz, Vernon S.
    Lambrechts, Diether
    Wildiers, Hans
    Van Ongeval, Chantal
    Van Limbergen, Erik
    Kristensen, Vessela
    Alnaes, Grethe Grenaker
    Nord, Silje
    Borresen-Dale, Anne-Lise
    Nevanlinna, Heli
    Muranen, Taru A.
    Aittomaeki, Kristiina
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (05):
  • [38] Multiple Genetic Variants in Telomere Pathway Genes and Breast Cancer Risk
    Shen, Jing
    Gammon, Marilie D.
    Wu, Hui-Chen
    Terry, Mary Beth
    Wang, Qiao
    Bradshaw, Patrick T.
    Teitelbaum, Susan L.
    Neugut, Alfred I.
    Santella, Regina M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (01) : 219 - 228
  • [39] Genetic Variants of the Sulfotransferase 1A1 and Breast Cancer Risk
    Uwe Langsenlehner
    Peter Krippl
    Wilfried Renner
    Babak Yazdani-Biuki
    Tanja Eder
    Gerald Wolf
    Thomas C. Wascher
    Bernhard Paulweber
    Werner Weitzer
    Hellmut Samonigg
    Breast Cancer Research and Treatment, 2004, 87 : 19 - 22
  • [40] Genetic variants of CYP19 (aromatase) and breast cancer risk
    Vessela Nedelcheva Kristensen
    Nobuhiro Harada
    Noriko Yoshimura
    Ellen Haraldsen
    P E Lønning
    Bjørn Erikstein
    Rolf Kåresen
    Tom Kristensen
    Anne-Lise Børresen-Dale
    Oncogene, 2000, 19 : 1329 - 1333